Viz AAA vs VX1
AI Verdict
Choose Viz AAA if…
Choose Viz AAA if your institution needs to rapidly identify and prioritize suspected Abdominal Aortic Aneurysm (AAA) cases directly from CT angiography scans. This tool is ideal for emergency departments, radiology, and vascular surgery teams seeking to accelerate diagnosis, streamline care coordination, and enable real-time communication for urgent interventions.
View Viz AAA →Choose VX1 if…
Choose VX1 if your cardiac electrophysiology lab aims to enhance the precision and standardization of atrial fibrillation and atrial tachycardia ablation procedures. This AI software is best suited for cardiologists performing complex ablations, as it provides real-time, AI-guided identification of dispersed electrograms to reduce inter-operator variability and potentially improve procedural outcomes.
View VX1 →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Viz AAA | VX1 |
|---|---|---|
| Pricing | Enterprise (hospital/health system) | Contact for pricing |
| Deployment | Cloud-based, integrates with PACS and EHR systems. | Software integrated with existing electrophysiology (EP) lab mapping and recording systems. |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Viz AAAViz AAA (Tool A) offers broader usability with cloud-based deployment, mobile access to imaging, and a communication platform for multidisciplinary teams, facilitating wider integration into hospital workflows. VX1 (Tool B) focuses on highly specialized integration within the EP lab, limiting its general usability across a broader care continuum.
Clinical Value
TieBoth tools are FDA-cleared and provide significant clinical value in their respective specialized domains. Viz AAA (Tool A) accelerates diagnosis for a critical, time-sensitive condition, while VX1 (Tool B) aims to standardize complex surgical outcomes, making it difficult to definitively rank one's clinical impact above the other without specific comparative outcome data.
Pricing & Value
Viz AAAWhile neither tool offers public pricing, Viz AAA (Tool A) provides a clearer framework for its subscription model, detailing that fees are based on the number of algorithms used and the size of the population served. This offers slightly more transparency in its pricing approach compared to VX1's (Tool B) simple 'contact for pricing' statement.
Enterprise Readiness
Viz AAAViz AAA (Tool A) explicitly states HIPAA compliance and the availability of a Business Associate Agreement (BAA), which are critical for enterprise adoption in healthcare. Its cloud-based deployment and integration into existing hospital workflows also demonstrate strong readiness for large-scale implementation.
Innovation
Viz AAAViz AAA (Tool A) holds the distinction of being the 'first FDA-cleared AI-powered solution' for its specific application of AAA detection and triage, indicating a pioneering innovation in that field. While VX1 (Tool B) offers innovative real-time guidance for complex EP procedures, Tool A's 'first-in-class' status gives it a slight edge in terms of groundbreaking innovation.
Support & Docs
Viz AAAViz.ai (Tool A) offers more comprehensive and readily accessible support resources, including 24/7 urgent phone support, email support, a Help Center, and dedicated customer success teams. While Volta Medical (Tool B) provides essential documentation like user manuals and IFUs, Viz.ai's support ecosystem appears more robust.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Viz AAA | VX1 |
|---|---|---|
| Name | Viz AAA | VX1 |
| Company | Viz.ai | Volta Medical |
| Primary Clinical Application | Detection and triage of suspected Abdominal Aortic Aneurysm (AAA) from CT angiography scans. | Assists cardiac electrophysiologists in real-time identification of dispersed electrograms during atrial fibrillation and atrial tachycardia ablation procedures. |
| Target Specialties | Emergency Medicine, Radiology, Vascular Surgery | Cardiology |
| Core AI Functionality | AI-powered automatic detection of suspected AAA, automated triage and prioritization, real-time alerts. | AI-guided real-time identification of dispersed electrograms (EGMs), analyzes 3D anatomical and electrical maps, provides cycle length estimation. |
Videos
Demos, reviews, and walkthroughs featuring Viz AAA and VX1.